Exclusive: Two London hospital trusts to trial tool that can predict those at risk up to 13 years before condition develops
The NHS in England is launching a world-first trial of a “gamechanging” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before they develop the condition.
More than 500 million people worldwide have type 2 diabetes, and finding new ways to spot people at risk before they develop the condition is a major global health priority. Estimates suggest 1 billion people will have type 2 diabetes by 2050.
About Author
More Stories
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Trump extends deadline for TikTok sale to non-Chinese buyer to avoid ban
Genetic data is an another asset to be exploited – beware who has yours | John Naughton